Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Medullary thyroid cancer (MTC) arises from RET proto-oncogene mutations, either hereditary or sporadic.
• RET mutations in the cysteine-rich region (MEN2A-like) and kinase domain (MEN2B-like) correlate with distinct clinical phenotypes.

Purpose of the Study:

• To analyze the whole-gene expression profile of MTC in relation to RET gene mutation type and hereditary versus sporadic origin.
• To identify specific genes whose expression is influenced by the location of RET mutations.

Main Methods:

• Studied gene expression profiles of 86 MTC samples.
• Correlated gene expression with RET mutation type (MEN2A-like vs. MEN2B-like) and genetic background (hereditary vs. sporadic).

Main Results:

• No significant differences in gene expression profiles were found between hereditary and sporadic MTC, suggesting a homogeneous nature.
• The site of RET gene mutation showed a slight influence on the gene expression profile.
• Significant associations were found between RET mutation localization and the expression of NNAT, CDC14B, and NTRK3 genes.

Conclusions:

• Medullary thyroid cancer exhibits a largely homogeneous gene expression profile.
• NNAT, CDC14B, and NTRK3 gene deregulation is linked to specific RET mutation types (MEN2A-like and MEN2B-like).
• Further research is needed to determine the clinical significance of these gene expression alterations.